Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana

Biotechnology Letters

Volumn 26, Issue 10, 2004, Pages 787-792

  Wu, H ^a   Singh, N K ^a   Locy, R D ^a   Scissum Gunn, K ^b   Giambrone, J J ^a  

^a AUBURN UNIVERSITY   (United States)

^b ALABAMA STATE UNIVERSITY   (United States)

Author keywords

Edible vaccines; Infectious bursal disease virus; Transgenic plant; VP2

Indexed keywords

RECOMBINANT PROTEIN; VIRUS PROTEIN; VIRUS VACCINE; VP2 PROTEIN, INFECTIOUS BURSAL DISEASE VIRUS;

ANIMAL; ARABIDOPSIS; ARTICLE; BIOSYNTHESIS; CHICKEN; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY; PLANT LEAF; PROTEIN ENGINEERING; TRANSGENIC PLANT; VIRUS INFECTION;

ANIMALS; ARABIDOPSIS; BIRNAVIRIDAE INFECTIONS; CHICKENS; GENE EXPRESSION REGULATION, PLANT; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

AGROBACTERIUM; AGROBACTERIUM TUMEFACIENS; ARABIDOPSIS; ARABIDOPSIS THALIANA; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS; RHIZOBIUM; VECTORS;

EID: 3342970512     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BILE.0000025878.30350.d5     Document Type: Article

References (32)

1. Azad AA, Barrett SA, Fahey KJ (1985) The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectiouous bursal disease virus. Virology 143: 35-44.
2. Azad AA, Jagadish MN, Brown AM, Hudson PJ (1987) Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161: 145-152.
3. Bayliss CD, Peters RW, Cook JKA, Reece RL, Houes K, Binns MM, Boursnell MEG (1991) A recombinant fowl poxvirus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Viral. 120: 193-205.
4. Bechtold N, Ellis J, Pelletier G (1993) In planta Agrobacterium mediated gene transfer by infiltration of adult Arabidopsis thaliana plants. C.R. Acad. Sci. Paris, Life Sci. 316: 1194-1199.
5. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248-254.
6. Carrillo C, Wigdorovitz A, Oliveros JC, Zamorano PI, Sadir AM, Gòmez N, Salinas J, Escribano JM, Borca MV (1998) Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 72: 1688-1690.
7. Corley MM, Giambrone JJ, Dormitorio TV (2001) Detection of infectious bursal disease vaccine viruses in lymphoid tissues after in ovo vaccination of specific pathogen free embryos. Avian Dis. 45: 897-905.
8. Dybing JK, Jackwood DJ (1997) Expression of MD infectious bursal disease viral proteins in baculovirus. Avian Dis. 41: 617-626.
9. Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming - production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 5: 219-226.
10. Gòmez N. Carrillo C, Salines J, Purra F, Borca MV, Escribano JM (1998) Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology 249: 352-358.
11. Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268: 714-716.
12. Jackwood DJ, Saif YM (1987) Antigenic diversity of infectious bursal disease viruses. Avian Dis. 43: 766-770.
13. Jagadish MN, Station VJ, Hudson PJ, Azad AA (1998) Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide. J. Virol. 62: 1084-1087.
14. Kibenge FSH, Jackwood DJ, Mercado CC (1990) Nucleotide sequence analysis of genome segment A of infectious bursal disease virus. J. Gen. Virol. 71: 569-577.
15. Kong QX, Ritchter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 20: 11539-11544.
16. Lauterslager TGM, Florack DEA, van der Wal TJ, Molthoff JW, Langeveld JPM, Bosch D, Boersma WJA, Hilgers LAT (2001) Oral immunization of naïve and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19: 2749-2755.
17. Lee CC, Ko TP, Lee MS, Chou CC, Lai SY, Wang AH, Wang MY (2003) Purification, crystallization and preliminary X-ray analysis of immunogenic virus-like particles formed by infectious bursal disease virus (IBDV) structural protein VP2. Acta Crystallogr. D Biol Crystallogr. 59: 1234-1237.
18. Macreadie IG, Vaughan PR, Chapman AJ, Mckern NM, Jagadish MN, Heine HG, Ward CW, Fahey KJ, Azad AA (1990) Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine 8: 549-552.
19. Mason HS, Bali JM, Shi JJ, Jiang X, Estes MK, Arntez CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93: 5335-5340.
20. Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT). Vaccine 16: 1336-1343.
21. Mason HS, Lam DMK, Arntzen, CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89: 11745-11749.
22. McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, Koprowski H, Michaels FH (1995) Expression of rabies virus glycoprotein in transgenic tomatoes. BioTechniques 13: 1484-1487.
23. Min N, Cui DC, Einstein J, Narasimhulu S, Vergara CE, Gelvin SB (1995) Strength and tissue specificity of chimeric promoters derived from the octopine and mannopine synthase genes. Plant J. 7: 661-676.
24. Ritchter LJ, Thanava Y, Arntzen CJ, Mason HS (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18: 1167-1171.
25. Sambrook J, Fritsh EF, Maniatis T (1989), Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
26. Shalaby WS (1995) Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin. Immunol. Immunopathol. 74: 127-134.
27. Sheppard M, Werner W, Tsatas E, McCoy R, Prouse S, Johnson M (1998) Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143: 915-930.
28. Snyder DB, Vakharia VN, Savage PK (1992) Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. Arch. Virol. 127: 89-101.
29. Spies U, Muller H, Becht (1987) Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res. 8: 127-140.
30. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4: 607-609.
31. Tsukamoto K, Kojima C, Komori Y, Tanimura N, Mase M, Yamaguehi S (1999) Protection of chicken against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 257: 352-362.
32. Wigdorovitz A, Carrillo C, Santos MJD, Trono K, Peralta A, Gòmez MC, Ríos RD, Franzone PM, Sadir AM, Escribano JM, Borca MV (1999) Induction of a protective antibody response to foot-and-mouth disease virus in mice following oral or potential immunization with alfalfa transgenic plants expressing the oral structural protein VP1. Virology 255: 347-353.